您的位置: 首页 > 农业专利 > 详情页

bispecific antibody against bcma and cd3 and an immunological drug for combined use in the treatment of multiple myeloma
专利权人:
ENGMAB SÁRL
发明人:
BRUNO DAVID LOURENÇO PAIVA,JESÚS FERNANDO SAN MIGUEL IZQUIERDO,KLAUS STREIN,MINH DIEM VU
申请号:
BR112019008426
公开号:
BR112019008426A2
申请日:
2017.11.02
申请国别(地区):
BR
年份:
2019
代理人:
摘要:
The invention relates to a bispecific antibody that specifically binds to a human b cell maturation antigen (bcma) and human cd3¿ (cd3) together with an immunotherapeutic drug for combined use in the treatment of multiple myeloma.a invenção refere-se a um anticorpo biespecífico que se liga especificamente a um antígeno de maturação de célula b humana (bcma) e a cd3¿ humano (cd3) junto com um fármaco imunoterapêutico para uso combinado no tratamento de mieloma múltiplo.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充